Ignite Creation Date:
2024-05-06 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05690048
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-23
First Post:
2022-12-13
Brief Title:
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to AtezolizumabBevacizumab FLORA
Sponsor:
Michael Dill
Organization:
University Hospital Heidelberg
Organization Data
Organization:
University Hospital Heidelberg
Class:
OTHER
Study ID:
Version 1007122022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Michael Dill
Lead Sponsor Class:
OTHER
Responsible Party:
Michael Dill
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Heidelberg
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Universitätsmedizin Mannheim | OTHER |
| National Center for Tumor Diseases Heidelberg | OTHER |
| German Cancer Research Center | OTHER |
| Heidelberg University | OTHER |
| University of Cologne | OTHER |